Sunday, 22 November 2026 Every SEC filing alert, by company
ALFAFINDER USA Filings Every alert, straight from SEC EDGAR
News

Cel Sci Corp

NYSE: CVM · Life Sciences · 1 alert · CIK 725363

Share price
$1.21Close, Nov 20
Market cap
$25.9M
Shares outstanding
17.59MLatest SEC cover page
Sector
Life Sciences
Industry
Biological Products, (No Diagnostic Substances)SIC 2836

Today's reference numbers: price from the latest market close, market cap from Nasdaq's listing data (else SEC cover-page shares × price), shares from the latest SEC cover page. Not a valuation or a recommendation. All Cel Sci Corp filings on SEC EDGAR ↗

6:03 AM ET 8-K
Business Update

Cel Sci Business Update

CEL-SCI's cancer immunotherapy Multikine has been granted designation under the Saudi Food and Drug Authority’s (SFDA) New Accelerator Program for Drugs in Rare Diseases (NADR). This designation, submitted by partner Amarox, allows for a priority 160-working-day review of a forthcoming Marketing Authorization Application, potentially making Saudi Arabia the first commercial market for the drug in 2027 or 2028.

Counterparty
Amarox

Get Alerts

Get ALFAFINDER USA alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.